T. Lang, P. Nguyen, R. Peach, W. Gause, and C. Via, In Vivo CD86 Blockade Inhibits CD4+ T Cell Activation, Whereas CD80 Blockade Potentiates CD8+ T Cell Activation and CTL Effector Function, The Journal of Immunology, vol.168, issue.8, pp.3786-3792, 2002.
DOI : 10.4049/jimmunol.168.8.3786

D. Saverino, C. Tenca, D. Zarcone, A. Merlo, A. Megiovanni et al., CTLA-4 (CD152) inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonally distributed fashion, J Immunol, vol.162, pp.651-658, 1999.

I. Tirapu, E. Huarte, C. Guiducci, A. Arina, M. Zaratiegui et al., Low Surface Expression of B7-1 (CD80) Is an Immunoescape Mechanism of Colon Carcinoma, Cancer Research, vol.66, issue.4, pp.2442-2450, 2006.
DOI : 10.1158/0008-5472.CAN-05-1681

P. Zhou, X. Zheng, H. Zhang, Y. Liu, and P. Zheng, B7 Blockade Alters the Balance between Regulatory T Cells and Tumor-reactive T Cells for Immunotherapy of Cancer, Clinical Cancer Research, vol.15, issue.3, pp.960-970, 2009.
DOI : 10.1158/1078-0432.CCR-08-1611

G. Freeman, A. Long, Y. Iwai, K. Bourque, T. Chernova et al., Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation, The Journal of Experimental Medicine, vol.142, issue.7, pp.1027-1034, 2000.
DOI : 10.1016/0008-8749(91)90091-O

M. Butte, V. Pena-cruz, M. Kim, G. Freeman, and A. Sharpe, Interaction of human PD-L1 and B7-1, Molecular Immunology, vol.45, issue.13, pp.3567-3572, 2008.
DOI : 10.1016/j.molimm.2008.05.014

H. Dong, S. Strome, D. Salomao, H. Tamura, F. Hirano et al., Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion, Nat Med, vol.8, pp.793-800, 2002.

J. Liu, A. Hamrouni, D. Wolowiec, V. Coiteux, K. Kuliczkowski et al., Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-?? and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway, Blood, vol.110, issue.1, pp.296-304, 2007.
DOI : 10.1182/blood-2006-10-051482

. Grellier, Molecular Cancer http://www.molecular-cancer.com/content, p.105105, 2011.

W. Zou and L. Chen, Inhibitory B7-family molecules in the tumour microenvironment, Nature Reviews Immunology, vol.106, issue.6, pp.467-477, 2008.
DOI : 10.1038/nri2326

A. Saudemont, A. Hamrouni, P. Marchetti, J. Liu, N. Jouy et al., Dormant Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1, Cancer Research, vol.67, issue.9, pp.4491-4498, 2007.
DOI : 10.1158/0008-5472.CAN-06-1627

A. Saudemont, N. Jouy, D. Hetuin, and B. Quesnel, NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells, Blood, vol.105, issue.6, pp.2428-2435, 2005.
DOI : 10.1182/blood-2004-09-3458

A. Saudemont and B. Quesnel, In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis, Blood, vol.104, issue.7, pp.2124-2133, 2004.
DOI : 10.1182/blood-2004-01-0064

B. Quesnel, Tumor dormancy and immunoescape???, APMIS, vol.20, issue.7-8, pp.685-694, 2008.
DOI : 10.1111/j.1600-0463.2008.01163.x

P. Chames, M. Van-regenmortel, E. Weiss, and D. Baty, Therapeutic antibodies: successes, limitations and hopes for the future, British Journal of Pharmacology, vol.163, issue.2, pp.220-233, 2009.
DOI : 10.1111/j.1476-5381.2009.00190.x

S. Campos and M. Barry, Current Advances and Future Challenges in Adenoviral Vector Biology and Targeting, Current Gene Therapy, vol.7, issue.3, pp.189-204, 2007.
DOI : 10.2174/156652307780859062

P. Hendrie and D. Russell, Gene Targeting with Viral Vectors, Molecular Therapy, vol.12, issue.1, pp.9-17, 2005.
DOI : 10.1016/j.ymthe.2005.04.006

URL : http://dx.doi.org/10.1016/j.ymthe.2005.04.006

W. Russell, Update on adenovirus and its vectors, Journal of General Virology, vol.81, issue.11, pp.2573-2604, 2000.
DOI : 10.1099/0022-1317-81-11-2573

W. Russell, Adenoviruses: update on structure and function, Journal of General Virology, vol.90, issue.1, pp.1-20, 2009.
DOI : 10.1099/vir.0.003087-0

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.322.9094

J. Short, C. Vasu, M. Holterman, D. Curiel, and A. Pereboev, Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors, Virus Research, vol.122, issue.1-2, pp.144-153, 2006.
DOI : 10.1016/j.virusres.2006.07.009

I. Ulasov, A. Rivera, Y. Han, D. Curiel, Z. Zhu et al., Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells, Journal of Neurosurgery, vol.107, issue.3, pp.617-627, 2007.
DOI : 10.3171/JNS-07/09/0617

L. Law and B. Davidson, What Does It Take to Bind CAR?, Molecular Therapy, vol.12, issue.4, pp.599-609, 2005.
DOI : 10.1016/j.ymthe.2005.05.017

URL : http://dx.doi.org/10.1016/j.ymthe.2005.05.017

H. Wang, Z. Li, Y. Liu, J. Persson, I. Beyer et al., Desmoglein 2 is a receptor for adenovirus serotypes 3, Nat Med, vol.7, issue.17, pp.11-1496, 2011.

L. Renaut, C. Bernard, D. Halluin, and J. , A rapid and easy method for production and selection of recombinant adenovirus genomes, Journal of Virological Methods, vol.100, issue.1-2, pp.121-131, 2002.
DOI : 10.1016/S0166-0934(01)00407-4

L. Renaut, C. M. Leite, J. Benko, M. , D. Halluin et al., Abolition of hCAR-dependent cell tropism using fiber knobs of Atadenovirus serotypes, Virology, vol.321, issue.2, pp.189-204, 2004.
DOI : 10.1016/j.virol.2003.12.023

S. Rogée, E. Grellier, C. Bernard, C. M. , D. Halluin et al., Non-heparan sulfate GAG-dependent infection of cells using an adenoviral vector with a chimeric fiber conserving its KKTK motif, Virology, vol.380, issue.1, pp.60-68, 2008.
DOI : 10.1016/j.virol.2008.07.019

S. Rogée, E. Grellier, C. Bernard, N. Jouy, A. Loyens et al., Influence of chimeric human-bovine fibers on adenoviral uptake by liver cells and the antiviral immune response, Gene Therapy, vol.14, issue.7, pp.880-891, 2010.
DOI : 10.1038/gt.2010.37

S. Rogée, E. Grellier, C. Bernard, A. Loyens, J. Beauvillain et al., Intracellular Trafficking of a Fiber-modified Adenovirus Using Lipid Raft/Caveolae Endocytosis, Molecular Therapy, vol.15, issue.11, pp.1963-1972, 2007.
DOI : 10.1038/sj.mt.6300283

T. Yamazaki, H. Akiba, H. Iwai, H. Matsuda, M. Aoki et al., Expression of Programmed Death 1 Ligands by Murine T Cells and APC, The Journal of Immunology, vol.169, issue.10, pp.5538-5545, 2002.
DOI : 10.4049/jimmunol.169.10.5538

M. Kamal, M. Marquez, V. Vauthier, A. Leloire, P. Froguel et al., Improved donor/acceptor BRET couples for monitoring ??-arrestin recruitment to G protein-coupled receptors, Biotechnology Journal, vol.5, issue.9, pp.1337-1344, 2009.
DOI : 10.1002/biot.200900016

URL : https://hal.archives-ouvertes.fr/hal-00495062

L. Mailly, L. Renaut, S. Rogée, E. Grellier, D. Halluin et al., Improved gene delivery to B lymphocytes using a modified adenovirus vector targeting CD21, Molecular Therapy, vol.14, issue.2, pp.293-304, 2006.
DOI : 10.1016/j.ymthe.2006.03.017

P. Boulanger and F. Puvion, Large-Scale Preparation of Soluble Adenovirus Hexon, Penton and Fiber Antigens in Highly Purified Form, European Journal of Biochemistry, vol.38, issue.1, pp.37-42, 1973.
DOI : 10.1016/0005-2795(72)90001-3

L. Franqueville, P. Henning, M. Magnusson, E. Vigne, G. Schoehn et al., Protein Crystals in Adenovirus Type 5-Infected Cells: Requirements for Intranuclear Crystallogenesis, Structural and Functional Analysis, PLoS ONE, vol.116, issue.8, p.2894, 2008.
DOI : 10.1371/journal.pone.0002894.g013

V. Molinier-frenkel, R. Lengagne, F. Gaden, S. Hong, J. Choppin et al., Adenovirus Hexon Protein Is a Potent Adjuvant for Activation of a Cellular Immune Response, Journal of Virology, vol.76, issue.1, pp.127-135, 2002.
DOI : 10.1128/JVI.76.1.127-135.2002

URL : https://hal.archives-ouvertes.fr/hal-00117255

V. Molinier-frenkel, A. Prévost-blondel, S. Hong, R. Lengagne, S. Boudaly et al., The Maturation of Murine Dendritic Cells Induced by Human Adenovirus Is Mediated by the Fiber Knob Domain, Journal of Biological Chemistry, vol.278, issue.39, pp.37175-37182, 2003.
DOI : 10.1074/jbc.M303496200

URL : https://hal.archives-ouvertes.fr/hal-00118794

M. Ayoub, A. Levoye, P. Delagrange, and R. Jockers, Preferential Formation of MT1/MT2 Melatonin Receptor Heterodimers with Distinct Ligand Interaction Properties Compared with MT2 Homodimers, Molecular Pharmacology, vol.66, issue.2, pp.312-321, 2004.
DOI : 10.1124/mol.104.000398

J. Bacart, C. Corbel, R. Jockers, S. Bach, and C. Couturier, The BRET technology and its application to screening assays, Biotechnology Journal, vol.6, issue.3, pp.311-324, 2008.
DOI : 10.1002/biot.200700222

H. Nishimura and T. Honjo, PD-1: an inhibitory immunoreceptor involved in peripheral tolerance, Trends in Immunology, vol.22, issue.5, pp.265-268, 2001.
DOI : 10.1016/S1471-4906(01)01888-9

M. Kocan, H. See, R. Seeber, K. Eidne, and K. Pfleger, Demonstration of Improvements to the Bioluminescence Resonance Energy Transfer (BRET) Technology for the Monitoring of G Protein-Coupled Receptors in Live Cells, Journal of Biomolecular Screening, vol.13, issue.9, pp.888-898, 2008.
DOI : 10.1177/1087057108324032

S. Shimozono and A. Miyawaki, Engineering FRET Constructs Using CFP and YFP, Methods Cell Biol, vol.85, pp.381-393, 2008.
DOI : 10.1016/S0091-679X(08)85016-9

S. Bhatia, K. Sun, S. Almo, S. Nathenson, and R. Hodes, Dynamic Equilibrium of B7-1 Dimers and Monomers Differentially Affects Immunological Synapse Formation and T Cell Activation in Response to TCR/CD28 Stimulation, The Journal of Immunology, vol.184, issue.4, pp.1821-1828, 2010.
DOI : 10.4049/jimmunol.0902869

J. Schwartz, X. Zhang, S. Nathenson, and S. Almo, Structural mechanisms of costimulation, Nature Immunology, vol.3, issue.5, pp.427-434, 2002.
DOI : 10.1038/ni0502-427

N. Boute, K. Pernet, and T. Issad, Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer, Mol Pharmacol, vol.60, pp.640-645, 2001.

P. Fender, R. Ruigrok, E. Gout, S. Buffet, and J. Chroboczek, Adenovirus dodecahedron, a new vector for human gene transfer, Nature Biotechnology, vol.18, issue.1, pp.52-56, 1997.
DOI : 10.1016/0378-1119(94)90302-6

P. Fender, G. Schoehn, J. Foucaud-gamen, E. Gout, A. Garcel et al., Adenovirus Dodecahedron Allows Large Multimeric Protein Transduction in Human Cells, Journal of Virology, vol.77, issue.8, pp.4960-4964, 2003.
DOI : 10.1128/JVI.77.8.4960-4964.2003

P. Fender, G. Schoehn, F. Perron-sierra, G. Tucker, and H. Lortat-jacob, Adenovirus dodecahedron cell attachment and entry are mediated by heparan sulfate and integrins and vary along the cell cycle, Virology, vol.371, issue.1, pp.155-164, 2008.
DOI : 10.1016/j.virol.2007.09.026

URL : https://hal.archives-ouvertes.fr/hal-00274496

E. Gout, G. Schoehn, D. Fenel, H. Lortat-jacob, and P. Fender, The Adenovirus Type 3 Dodecahedron's RGD Loop Comprises an HSPG Binding Site That Influences Integrin Binding, Journal of Biomedicine and Biotechnology, vol.3, issue.12, 2010.
DOI : 10.1128/JVI.00843-06

S. Hong, B. Gay, L. Karayan, M. Dabauvalle, and P. Boulanger, Cellular Uptake and Nuclear Delivery of Recombinant Adenovirus Penton Base, Virology, vol.262, issue.1, pp.163-177, 1999.
DOI : 10.1006/viro.1999.9864

F. Gaden, L. Franqueville, M. Magnusson, S. Hong, M. Merten et al., Gene Transduction and Cell Entry Pathway of Fiber-Modified Adenovirus Type 5 Vectors Carrying Novel Endocytic Peptide Ligands Selected on Human Tracheal Glandular Cells, Journal of Virology, vol.78, issue.13, pp.7227-7247, 2004.
DOI : 10.1128/JVI.78.13.7227-7247.2004

URL : https://hal.archives-ouvertes.fr/hal-00120203

R. Thompson, M. Gillett, J. Cheville, C. Lohse, H. Dong et al., Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target, Proceedings of the National Academy of Sciences, vol.101, issue.49, pp.17174-17179, 2004.
DOI : 10.1073/pnas.0406351101

. Grellier, Molecular Cancer http://www.molecular-cancer.com/content, p.105105, 2011.